Search
Close this search box.
Search
Close this search box.

January 2023

5th Lao-Thai Friendship Bridge expected to be opened in 2024

The 5th Lao-Thai Friendship Bridge spanning the Mekong between Borikhamxay Province of Laos and Bung Kan Province of Thailand is expected to be completed and opened in early 2024.Since October 2022, 60 per cent of the bridge construction plan has been …

Cheaters Beware: ChatGPT Maker Releases AI Detection Tool

The maker of ChatGPT is trying to curb its reputation as a freewheeling cheating machine with a new tool that can help teachers detect if a student or artificial intelligence wrote that homework.The new AI Text Classifier launched Tuesday by OpenAI fol…

Fortinet Expands its Services and Training Offerings to Further Support SOC Teams in Preventing and Defending Against Cyber Threats

Multi-Faceted Approach Accelerates Fortinet’s Global Commitment to Eliminate the Cybersecurity Skills Gap SUNNYVALE, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) — John Maddison, EVP of Products and CMO at Fortinet “Fortinet builds ML-driven automation into all of its SOC offerings to support short-staffed teams affected by the cybersecurity skills shortage. But technology alone won’t solve this […]

Cozycozy is the Only Accommodation Search Engine That Now Includes Airbnb, Giving Travelers the Largest Selection of Vacation Rentals Possible

One search, so many possibilities – cozycozy helps users find their perfect holiday accommodation from over 100+ booking platforms, including Airbnb. cozycozy Amalfi coast NEW YORK, Jan. 30, 2023 (GLOBE NEWSWIRE) — Cozycozy knows that finding the perfect place to stay can be hard. With the rise of so many vacation rental and hotel platforms […]

Junshi Biosciences Announces Approval for Marketing of VV116 in China

SHANGHAI, China, Jan. 30, 2023 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the National Medical Products Administration (the “NMPA”) has conducted urgent review and approval under Special Examination and Approval […]

Survey demonstrates that individuals with COPD seek more options to reduce risks of seasonal respiratory viral infections

— ENA Respiratory and COPD Foundation survey confirms patients are overwhelmingly positive about taking an immune-modulating nasal spray to reduce lung disease exacerbations– — Survey was conducted through COPD360Net®, an innovative COPD Foundation program that identifies unmet patient needs and integrates the patient voice into therapy development– MIAMI and MELBOURNE, Australia, Jan. 30, 2023 (GLOBE […]